Phillips 66 (PSX) target raised at Oppenheimer to $55, Oppenheimer said. Outlook improved. Outperform rating.
Questcor (QCOR) estimates, target cut at BofA/Merrill. Shares of QCOR now seen reaching $45, according to Bank of America/Merrill Lynch. Estimates also reduced, following AET changes for Acthar. Buy rating.
Questcor Pharmaceuticals numbers lowered at Oppenheimer. Shares of QCOR now seen reaching $65, Oppenheimer said. Estimates also lowered on revision of Acthar coverage. Outperform rating.
Wyndham (WYN) estimates, target upped at Lazard. WYN estimates were boosted through 2013, Lazard said. Company is likely to buy back more stock. Buy rating and new $63 price target.>To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.